Activist 13D/13G Filings - GV 2017 L.P.

Real time Form 13D and 13G transaction reports:

  • Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
  • Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
  • Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
Time period
Reported
DateTime
TypeCompany
Symbol
Filed By
Symbol
Shares Owned
% Owned
Shares Vs. Prev ReportFiling
2024-11-08
4:20 pm
Purchase
13GBENSON HILL INC
BHIL
GV 2017 L.P.444,349
7.300%
444,349increase
(New Position)
View
2024-11-08
4:15 pm
Sale
13GGitlab Inc.
GTLB
GV 2017 L.P.9,758,333
7.100%
-1,777,755decrease
(-15.41%)
View
2024-02-09
4:08 pm
Unchanged
13GTScan Therapeutics Inc.
TCRX
GV 2017 L.P.1,077,080
2.500%
0
(Unchanged)
View
2024-02-09
4:06 pm
Purchase
13GGitlab Inc.
GTLB
GV 2017 L.P.11,536,088
9.900%
713,578increase
(+6.59%)
View
2023-12-11
4:16 pm
Purchase
13GVERVE THERAPEUTICS INC
VERV
GV 2017 L.P.12,349,086
15.400%
1,800,000increase
(+17.06%)
View
2023-03-24
4:15 pm
Purchase
13GGitlab Inc.
GTLB
GV 2017 L.P.10,822,510
10.800%
639,207increase
(+6.28%)
View
2023-02-10
4:05 pm
Purchase
13GBENSON HILL INC
BHIL
GV 2017 L.P.17,849,461
8.700%
3,097,190increase
(+20.99%)
View
2023-02-10
4:05 pm
Purchase
13GGitlab Inc.
GTLB
GV 2017 L.P.10,183,303
10.200%
1,294,527increase
(+14.56%)
View
2023-02-10
4:05 pm
Sale
13GVERVE THERAPEUTICS INC
VERV
GV 2017 L.P.10,549,086
17.100%
-424,925decrease
(-3.87%)
View
2022-02-14
5:15 pm
Purchase
13GVERVE THERAPEUTICS INC
VERV
GV 2017 L.P.10,974,011
22.780%
10,974,011increase
(New Position)
View
2022-02-14
4:14 pm
Purchase
13GGitlab Inc.
GTLB
GV 2017 L.P.8,888,776
41.360%
8,888,776increase
(New Position)
View
2022-02-14
1:07 pm
Purchase
13GBENSON HILL INC
BHIL
GV 2017 L.P.14,752,271
8.290%
14,752,271increase
(New Position)
View
2022-02-14
11:39 am
Purchase
13GTScan Therapeutics Inc.
TCRX
GV 2017 L.P.1,077,080
5.780%
1,077,080increase
(New Position)
View